Quincewood Limited
01762674
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 06/05/2026
Due 20/05/2027
Industry
Officers
Persons with Significant Control
Eclipse Pharma 2 Ltd
220-222, High Street, London, E17 7JH
Reg: 16311917 · Companies House Registrar · Private Limited Company
Notified 02/06/2025
Former PSCs
Mr Udaykumar Kantilal Patel
Ceased 16/04/2024
Quincewood Holdings Ltd
Ceased 02/06/2025
Charges0 outstanding
NATIONAL WESTMINSTER BANK PLC
CompanyRankvs 1875+ SIC 47730 peers63
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£100
Balance sheet strength
Cash
£1.2M
Cash in the bank
Net Current Assets
£1.2M
Working capital
Current Assets
£1.3M
Current Liabilities
£151k
Fixed Assets
£313
Debtors
£80k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 8.81 | — |
| 2024 | 6.54 | -£159k |
| 2023 | 7.07 | +£126k |
| 2022 | 6.38 | -£107k |
| 2021 | 6.80 | +£123k |
| 2020 | 8.21 | +£80k |
| 2019 | 7.88 | +£194k |
| 2017 | 5.75 | — |
Derived from filed accounts. Not audited figures.